<i>N</i>-甲基-<i>D</i>-天冬氨酸受体显像剂研究进展

颜成龙; 周杏琴; 曹国宪

doi:10.3760/cma.j.issn.1673-4114.2009.01.009

N-甲基-D-天冬氨酸受体显像剂研究进展

1. 江南大学医药学院生物制药系, 无锡 214122;
2. 卫生部核医学重点实验室, 江苏省原子医学研究所科研部, 无锡 214063
基金项目:
江苏省卫生厅重大科研项目(K200512)

国家自然科学基金(30770602)

Advance in studies of the tracer of N-methyl-D-aspartate receptor

1. School of Medicine and Pharmaceutics, Jiangnan University, Jiangsu Wuxi 214122, China;
2. Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Institute of Nuclear Medicine, Jiangsu Wuxi 214063, China

摘要: N-甲基-D-天冬氨酸(NMDA)受体已成为发展帕金森病、阿尔茨海默病、精神分裂症、癫痫、亨廷顿舞蹈症等神经变性疾病药物的新靶点。NMDA受体显像剂的研制将为神经变性疾病的早期诊断和治疗提供灵敏的分子探针和特异的诊断方法。多数NMDA受体显像剂因脂溶性和亲和力欠佳而不宜用于临床,有希望成为NMDA受体显像剂的是¹²³I-CNS1261。该文综述了近年来关于NMDA受体显像剂的研究进展。
- 受体,N-甲基-D-天冬氨酸 /
- 神经变性疾病 /
- 放射性核素显像
Abstract: N-methyl-D-aspartate receptors have recently been a novel target of drug development related to neurodegenerative diseases such as Parkinson diseases, Alzheimer disease, schizophrenia, epilepsy and Huntingtons disease. NMDA receptor imaging agents can provide a sensitive molecular prob and a powerful diagnostic tool for the early diagnosis and therapy of neurodegenerative diseases. Because of inadequate lipophilicity and affinity, many NMDA receptor imaging agents couldn't be used in clinical. ¹²³I-N-(1-napthyl)-N'-(3-iodophenyl)-N-methylguanidine (¹²³I-CNS1261)has the potential to be a NMDA receptor imaging agent. Basing on the researches which has accomplished in the abroad at present, this review concluded the progresses of the tracer of NMDA receptor.
- Receptors,N-methyl-D-aspartate /
- Neurodegenerative diseases /
- Radionuclide imaging
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Watkins JC,Jane DE.The glutamate story.Br J Pharmacol,2006,147(Suppl 1):S100-S108.
[2]	林奕斌,赵同军,展永.N-甲基-D-天氡氨酸受体的分子结构与生理功能.生物学杂志,2007,24(1):1-4.
[3]	Bendel O,Meijer B,Hurd Y,et al.Cloning and expression of the human NMDA receptor subunit NR3B in the adult human hippocampus.Neurosci Lett,2005,377(1):31-36.
[4]	Waxham WN.Neurotransmitter receptors//Zigmond M J,Bloom FE,Landis SC,et al.Fundamental neuroscience.London:Academic press,1999:251.
[5]	Yang Y,Wang XB,Frerking M,et al.Spine expansion and stabilization associated with long-term potentiation.J Neurosci,2008,28(22):5740-5751.
[6]	Wessell RH,Ahmed SM,Menniti FS,et al.NR2B selective NMDA receptor antagonist CP-101,606 prevents levedopa-indueed motor response alterations in hemi-parkinsonian rats.Neuropharmacology,2004,47(2):184-194.
[7]	Lipton SA.The molecular basis of menmantine action in Alzheimer's disease and other neurologic disorders:low-afflnity,uneompetitive antagonism.Curt Alzheimor Res,2005,2(2):155-165.
[8]	Loftis JM,Janowsky A.The N-methyl-D-aspartate recepor subunit NR2B:localization,functional properties,regulation,and clinical implications.Pharmacol Ther,2003,97(1):55-85.
[9]	Hahn CG,Wang HY,Cho DS,et al.Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.Nat Med,2006,12(7):824-828.
[10]	Narita M,Aoki T,Suzuki T.Moecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference.Neuroscience,2000,101(3):601-606.
[11]	Yukewicz L,Weaver J,Bullock MR,et al.The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury.J Neurotrauma,2005,22(12):1428-1443.
[12]	Wang CX,Shuaib A.NMDA/NR2B selective antagonists in the treatment of iachemie brain injury.Curt Drug Targets CNS Neurol Disord,2005,4(2):143-151.
[13]	Guo W,Wei F,Zou S,et al.Group I metabotropic gluatmate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrnsine phosphorylation associated with inflammatory hyperalgesia.J Neurosci,2004,24(41):9161-9173.
[14]	Bajo M,Crawford EF,Roberto M,et al.Chronic morphine treatment alters expression of N-methyl-D-asparate receptor subunits in the extended amygdala.J Neurnsci Res,2006,83(4):532-537.
[15]	Owens J,Wyper DJ,Patterson J,et al.First SPET images of glutaroate(NMDA) receptor activation in vivo in cerebral ischacmia.Nucl Med Commun,1997,18(2):149-158.
[16]	Elfverson M,Linde AM,Le Greves P,et al.Neuresteroids allosterically modulate the ion pore of the NMDA receptor consisting of NR1/NR2B but not NR1/NR2A.Biochem Biophys Res Commun,2008,327(2):305-308.
[17]	Kiesewetter DO,Finn RD,Rice KC,et al.Synthesis of ¹¹C-labeled (+-)-5-methyl-10,11-dihydre-5H-dibenzo[a,d]cyclohepten-5,10-imin e[(+-)-[¹¹C]MK801].Int J Rad Appl Instrum[A],1990,41(2):139-142.
[18]	Samnick S,Ametamey SM,Leenders KL,et al.Electrophysiological study,biodistributian in mice,and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[¹⁸F]fluoromethyl-5-methyladamantane (¹⁸F-MEM):a potential radioligand for mapping the NMDA-receptor complex.Nucl Med Biol,1998,25(4):323-330.
[19]	Ametamey SM,Samnick S,Leenders KL,et al.Fluorine-18 radiolabelling,biedistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor.J Recept Siqnal Transduct Res,1999,19(1-4):129-141.
[20]	Ametamey SM,Bruehlmeier M,Kneifel S,et al.PET studies of ¹⁸F-memantine in healthy volunteers.Nucl Med Biol,2002,29(2):227-231.
[21]	张建康,周杏琴,钦晓峰,等.放射性^99mTc标记的NMDA受体配基N₂S₂-Memantine的合成.化学试剂,2008,30(11):842-844.
[22]	Bressan RA,Erlandsson K,Stone JM,et al.Impact of achizophrenia and chronic antipsychotie treatment on[¹²³I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo.Biol Psychiatry,2005,58(1):41-46.
[23]	Stone JM,Erlandsson K,Arstad E,et al.Ketamine displaces the novel NMDA receptor SPET probe[¹²³I]CNS-1261 in humans in vivo.Nucl Med Biol,2006,33(2):239-243.
[24]	Stone JM,Erlandsson K,Arstad E,et al.Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy:a[¹²³I]CNS-1261 SPET study.Psychopharmacolngy (Berl),2008,197(3):401-408.
[25]	Waterhoase RN,Slifstein M,Dumont F,et al.In vivo evaluation of[¹¹C]N-(2-chloro-5-thiomethylpbenyl)-N'-(3-methoxy-phenyl)-N'-me-thylguanidine ([¹¹C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor.Nucl Med Biol,2004,31(7):939-948.
[26]	Haradahira T,Okauchi T,Maeda J,et al.Effects of endogenous agonists,glyeine and D-serine,on in vivo specific binding of[¹¹C]L-703,717,a PET radioligand for the glycine-binding site of NMDA receptors.Synapse,2003,50(2):130-136.
[27]	Matsumoto R,Haradahira T,Ito H,et al.Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717,4-acetoxy-7-chloro-3-[3-(4-[¹¹C]methoxybenzyl) phenyl]-2(IH)-quinolons (AcL703) with positron emission tomography.Synapse,2007,61(10):795-800.
[28]	Fuchiqami T,Haradahira T,Fujimoto N,et al.Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel.Nucl Med Biol,2008,35(2):203-212.
[29]	Waterhonse RN,Sultana A,Laruelle M.In vivo evaluation of[¹¹C]3-[2[(3-methoxyphenylamino) carbonyl]ethenyl]-4,6-dichloroindole-2-caboxylic acid ([¹¹C]3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel.Nucl Med Biol,2002,29(8):791-794.

[1]	孔艳艳 , 周杏琴 , 曹国宪 . N-甲基-D-天冬氨酸受体与脑卒中的关系及其核素显像剂. 国际放射医学核医学杂志, 2010, 34(1): 6-11. doi: 10.3760/cma.j.issn.1673-4114.2010.01.002
[2]	夏俊勇 , 王火强 . 以血管内皮生长因子及其受体为靶向的肺癌放射性核素显像. 国际放射医学核医学杂志, 2008, 32(2): 82-85.
[3]	陈素芸 . 放射性核素标记RGD多肽在整合素受体显像中的应用. 国际放射医学核医学杂志, 2007, 31(3): 129-132.
[4]	王培 , 王帅亮 , 朱华 , 杨志 . 放射性核素探针在嵌合抗原受体T细胞治疗显像中的应用. 国际放射医学核医学杂志, 2023, 47(5): 302-307. doi: 10.3760/cma.j.cn121381-202206010-00290
[5]	邱春 , 管一晖 . 5-羟色胺受体显像剂在神经系统疾病及脑功能研究中的应用. 国际放射医学核医学杂志, 2011, 35(2): 73-80, 127. doi: 10.3760/cma.j.issn.1673-4114.2011.02.003
[6]	刘晓飞 , 张锦明 , 王洁磊 , 田嘉禾 . 放射性核素标记RGD序列多肽与整合素α_vβ₃受体显像的研究进展. 国际放射医学核医学杂志, 2008, 32(1): 12-15.
[7]	赵春雷 , 栗维国 , 罗锡圭 , 李亚明 . 核医学炎症显像对临床炎症性疾病的评价. 国际放射医学核医学杂志, 1996, 20(6): 250-254.
[8]	杨明福 , 李前伟 . 肿瘤血管内皮生长因子受体核素显像研究现状. 国际放射医学核医学杂志, 2010, 34(1): 19-22. doi: 10.3760/cma.j.issn.1673-4114.2010.01.005
[9]	赵娟 , 刘兴党 . 实验性近视眼视网膜多巴胺神经系统研究进展. 国际放射医学核医学杂志, 2007, 31(2): 73-76.
[10]	郭睿 , 晋建华 . ^99mTc-depreotide生长抑素受体显像的临床应用研究. 国际放射医学核医学杂志, 2007, 31(3): 154-157.
[11]	侯仁花 , 吕中伟 . 生长抑素受体显像剂^99mTc-depreotide的研究进展. 国际放射医学核医学杂志, 2008, 32(1): 15-18.

点击查看大图

计量

文章访问数: 1789
HTML全文浏览量: 313
PDF下载量: 3

N-甲基-D-天冬氨酸受体显像剂研究进展

Advance in studies of the tracer of N-methyl-D-aspartate receptor

计量

N-甲基-D-天冬氨酸受体显像剂研究进展

English Abstract

Advance in studies of the tracer of N-methyl-D-aspartate receptor

全文HTML

目录

N-甲基-D-天冬氨酸受体显像剂研究进展

Advance in studies of the tracer of N-methyl-D-aspartate receptor

计量

出版历程

N-甲基-D-天冬氨酸受体显像剂研究进展

English Abstract

Advance in studies of the tracer of N-methyl-D-aspartate receptor

全文HTML

目录